The drug, Journavx, from Vertex Pharmaceuticals, reduced pain after surgery in clinical trials. Experts hope it can lead to fewer opioid prescriptions.
It was given to people who had acute surgical pain from either abdominoplasty, also known as a tummy tuck, or bunion surgery.
In what seems a significant step forward in pain management, the US Food and Drug Administration has approved a new non-opioid painkiller for treating short-term pain in adults. Veuer’s Maria Mercedes ...
The U.S. Food and Drug Administration has approved Journavx (suzetrigine) 50 milligram oral tablets, marking the introduction of a first-in-class non-opioi ...
Federal officials approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated with ...
The recalled Braga Fresh Marketside Broccoli was washed, ready-to-eat, and sold in 12-ounce bags at Walmart stores in 20 states including Alaska, Arkansas, Arizona, California, Colorado, Idaho, ...
The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...
Unpatched vulnerabilities in Contec CMS8000 patient monitors expose devices to remote access, file overwrites, and data leaks ...
Discover the latest trends in the business world, from Barnes and Noble's growth fueled by BookTok to the FDA's approval of a new nonopioid pain medication.
A chocolate-covered pretzel product is being recalled in three states due to the presence of an undeclared milk allergen.
More than 10 million babies have been born through IVF, yet the process is still invasive and costly. Plus, why a venture ...
The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often ...